Shockwave Medical Inc.

As the primary committee for taxation, trade, and entitlement spending, it directly influences corporate tax policy and, critically, Medicare reimbursement rates, which are major revenue drivers and valuation factors for medical device companies.

This committee directly allocates discretionary federal spending, including for critical healthcare programs (e.g., Medicare, Medicaid, NIH, VA). These allocations determine the funding environment and reimbursement streams crucial for medical device sales and development.

This committee directly oversees the FDA, which is the primary regulatory body for medical device approvals, manufacturing standards, and post-market surveillance – all crucial for Shockwave Medical's operations and market access.

This committee's oversight of antitrust laws and intellectual property (patents) is critical for a medical device manufacturer, influencing potential mergers, market competition, and the protection of proprietary technology.

This committee directly oversees the Department of Veterans Affairs, whose funding decisions and healthcare policies significantly impact medical device manufacturers that sell to the VA healthcare system.